Future Fields harnesses insect biotechnology to make Earth’s most sustainable recombinant proteins.
Future Fields is committed to producing sustainable components for science through insect biotechnology. Its EntoEngine™ platform is the first to harness the genetic prowess of fruit flies to produce Earth’s most environmentally and economically sustainable biomolecules. Founded in 2018, Future Fields is headquartered in Edmonton, Canada and proudly backed by marquee venture capital firms and investors from Silicon Valley and beyond. Learn more about how Future Fields is enabling great science at https://futurefields.io/.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 23, 2023 | Series A | $15.10M | 1 | Toyota Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Toyota Ventures | Yes | Series A |